A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies
Clinical trial NCT04861779 · UNKNOWN
Trial details
- NCT number
- NCT04861779
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2023-08-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.